PRODUCTS
EditCo delivers efficient gene editing with guaranteed >80% efficiency in human primary cells, achieving >90% in many cases, using a smart multi-guide design and a 7-day protocol for results in 2 weeks or faster. Their Primary Cell KO Pools produce functionally consistent cell populations, ideal for drug discovery or biological modeling, while maintaining high viability and functionality. Researchers can use EditCo-supplied cells or their own CD8+/CD4+ T cells, ensuring flexibility and reliability. By minimizing failed experiments and false negatives, EditCo saves time and resources, offering 1M-cell EC Pools for high-quality, rapid, and dependable gene editing.
Their KO Primary T-cells ensure >80% editing efficiency, available with EditCo-supplied cells or your own experimental/clinical samples.
Options include EditCo-supplied cells or customer-provided samples, with edits available for single knockouts using multi-guide synthetic sgRNA.
Receive regular updates, 2 vials of edited cell pools (>1M cells/vial), control-transfected pools, gRNA sequences, NGS primers, sequencing reports, and a detailed QC analysis.
Each order includes a QC report with mycoplasma testing, passage number, and NGS analysis to ensure high-quality, functional edited cells.
Image: High editing efficiency across multiple donors.
Image: EditCo KO CD8+ T cell pools can be thawed and expanded for weeks, with or without TCR stimulation.
Take your research further with precision-engineered CD8+ T cells that combine high editing efficiency, long-term stability, and exceptional functionality. Designed to maintain their knockout integrity, expand effortlessly post-thaw, and deliver strong antigen-specific responses, these cells are built for performance. Whether you’re exploring immune responses or advancing cell therapy, these edited T cell pools provide the reliability and power you need.
🔬 Unmatched Editing Precision – Achieve over 90% knockout efficiency across multiple donors, maintaining stability before and after cryopreservation.
🧬 Thrives & Expands with Ease – These cells stay healthy and proliferate for weeks, with or without stimulation, ensuring flexibility in your experiments.
⚡ Optimized for Real-World Function – A single round of activation preserves normal function, preventing overstimulation and exhaustion.
🎯 Potent, Targeted Cytotoxicity – Strong antigen-specific activation, with robust CD107a expression, ensures effective tumor-killing potential.
Power up your research with CD8+ T cells engineered to perform when it matters most.
The editing of CD4+ T cells has shown high efficiency and stability, with a robust ability to maintain functionality after the editing process. The efficiency of the CD4+ T cell editing was determined through ICE analysis, with results demonstrating high editing efficacy across multiple loci while ensuring cell viability during the freezing stage. Post-editing, the cells can be thawed and expanded without loss of functionality or editing efficiency. Cytokine production in edited T cells, including IFNg, IL2, and TNFa, indicates that the editing process does not negatively impact the cells’ ability to produce essential cytokines upon stimulation. These edited pools also show high viability, making them suitable for further downstream assays.
Image: Editing Efficiency and Viability for CD4+ T cell pools.
Image: Editing Efficiency leads to protein depletion as shown by flow cytometry
Image: CD4+ pool stability after thaw.
Get a call from your local Decode Science representative to help you find the best fit genomics products for you.
Or give us a call at:
Simply add your details below and get quick access to the brochure.
Simply add your details below and get quick access to the brochure.
Simply add your details below and get quick access to the brochure.